Compliance: Clinical Trials

2 trials of Compliance, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Compliance: new trials by email Literature Review of Compliance trials Research Report on Compliance

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Improve Quality of Care and Patient Health in the Field of Cardiovascular Risk Factors in General Practice
Cardiovascular drugs strategies, Compliance, Exercise - High Risk Hypertensive Patients
Phase 4CompletedCollège National des Généralistes Enseignants18362006-11-012011-11-15
To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine
Compliance - AIDS
Phase 4CompletedBristol-Myers Squibb1202004-04-012011-04-22

Conditions studied

Acquired Immunodeficiency Syndrome (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Hypertension (1)

Sponsors

Bristol-Myers Squibb (1)  ·  Collège National des Généralistes Enseignants (1)

Countries

France (1)

Results publications

PMID 24083783, PMID 27178974